72 related articles for article (PubMed ID: 31363165)
1. The use of
Raveenthiran S; Yaxley J; Gianduzzo T; Kua B; McEwan L; Wong D; Tsang G; MacKean J
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):385-390. PubMed ID: 31363165
[TBL] [Abstract][Full Text] [Related]
2. Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis.
Subiela JD; Gomis Sellés E; Maldonado A; Lopez Campos F; Aumatell Ovide J; Ajuria Illarramendi O; González-Padilla DA; Gajate P; Ortega Polledo LE; Alonso Y Gregorio S; Guerrero-Ramos F; Gómez Dos Santos V; Rodríguez-Patrón R; Calais J; Kishan AU; Burgos Revilla FJ; Couñago F
Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):e676-e688. PubMed ID: 37802722
[TBL] [Abstract][Full Text] [Related]
3. Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.
Schmidt-Hegemann NS; Fendler WP; Ilhan H; Herlemann A; Buchner A; Stief C; Eze C; Rogowski P; Li M; Bartenstein P; Ganswindt U; Belka C
Radiat Oncol; 2018 Mar; 13(1):37. PubMed ID: 29499730
[TBL] [Abstract][Full Text] [Related]
4. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
[TBL] [Abstract][Full Text] [Related]
5. Seek and Find: Current Prospective Evidence for Prostate-specific Membrane Antigen Imaging to Detect Recurrent Prostate Cancer.
Keegan NM; Bodei L; Morris MJ
Eur Urol Focus; 2021 Mar; 7(2):267-278. PubMed ID: 33744163
[TBL] [Abstract][Full Text] [Related]
6. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?
Mahal BA; Chen MH; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV; Nguyen PL
Ann Oncol; 2015 Jul; 26(7):1390-5. PubMed ID: 25926039
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of bone scan at different PSA levels in biochemical recurrence of prostate cancer.
Singh KB; London KI; Wong VCK; Mansberg R
J Med Imaging Radiat Sci; 2024 Mar; 55(1):91-96. PubMed ID: 38216344
[TBL] [Abstract][Full Text] [Related]
8. The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer.
Bilusic M; Einstein DJ; Karzai FH; Dahut WL; Gulley JL; Aragon-Ching JB; Madan RA
Urol Clin North Am; 2020 Nov; 47(4):457-467. PubMed ID: 33008496
[TBL] [Abstract][Full Text] [Related]
9. Negative 18F-Piflufolastat PET/CT, But Positive 18F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer.
Ulaner GA
Clin Nucl Med; 2024 May; ():. PubMed ID: 38693630
[TBL] [Abstract][Full Text] [Related]
10. Incidental Detection of Synchronous Benign Hepatic and Splenic Hemangiomas on 18 F-PSMA PET/CT.
Alsaleh MH; Alkhars AS; Albensaad M; Alsharif A
Clin Nucl Med; 2024 Jun; 49(6):e298-e300. PubMed ID: 38537220
[TBL] [Abstract][Full Text] [Related]
11. A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer.
Hébert JR; Hurley TG; Harmon BE; Heiney S; Hebert CJ; Steck SE
Cancer Epidemiol; 2012 Apr; 36(2):e128-36. PubMed ID: 22018935
[TBL] [Abstract][Full Text] [Related]
12. PSMA-Avid Desmoid Tumor of the Abdominal Wall on 18F-Piflufolastat PET/CT.
Bommekal S; Flynt L; Tewari SO; Surasi DSS
Clin Nucl Med; 2024 May; ():. PubMed ID: 38739529
[TBL] [Abstract][Full Text] [Related]
13. Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?
Childs DS; Orme JJ; Ravi P
J Clin Oncol; 2024 Apr; 42(10):1095-1097. PubMed ID: 38261976
[No Abstract] [Full Text] [Related]
14. Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy.
Jansen BHE; van Leeuwen PJ; Wondergem M; van der Sluis TM; Nieuwenhuijzen JA; Knol RJJ; van Moorselaar RJA; van der Poel HG; Oprea-Lager DE; Vis AN
Eur Urol Oncol; 2021 Oct; 4(5):821-825. PubMed ID: 32088155
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice in prostate PET imaging.
Huls SJ; Burkett B; Ehman E; Lowe VJ; Subramaniam RM; Kendi AT
Ther Adv Med Oncol; 2023; 15():17588359231213618. PubMed ID: 38028142
[TBL] [Abstract][Full Text] [Related]
16. Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.
von Eyben R; Hoffmann MA; Soydal C; Virgolini I; Tuncel M; Gauthé M; Kapp DS; von Eyben FE
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760775
[TBL] [Abstract][Full Text] [Related]
17. Application of next-generation imaging in biochemically recurrent prostate cancer.
Moul JW; Shore ND; Pienta KJ; Czernin J; King MT; Freedland SJ
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):202-211. PubMed ID: 37679601
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiation Therapy Salvage for Lymph Node Recurrent Prostate Cancer in the Era of PSMA PET Imaging.
Hayek OE; Rais-Bahrami S; McDonald A; Galgano SJ
Curr Urol Rep; 2023 Oct; 24(10):471-476. PubMed ID: 37395949
[TBL] [Abstract][Full Text] [Related]
19. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis.
von Eyben R; Kapp DS; Hoffmann MA; Soydal C; Uprimny C; Virgolini I; Tuncel M; Gauthé M; von Eyben FE
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358880
[TBL] [Abstract][Full Text] [Related]
20. Predicting Local Failure after Partial Prostate Re-Irradiation Using a Dosiomic-Based Machine Learning Model.
Pirrone G; Matrone F; Chiovati P; Manente S; Drigo A; Donofrio A; Cappelletto C; Borsatti E; Dassie A; Bortolus R; Avanzo M
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
